None listed
Conditions
Interventions
Intervention1: Skin Brightening Face Oil: Mode of Usage: Apply 4-5 drops of the product on face and massage gently in circular motion and upward direction
Frequency: Twice Daily
Total Duration: 60 Day
Sponsors
S H Kelkar and Company Limited
Eligibility
Inclusion criteria
Inclusion criteria: 1) Age: 18 to 55 years at the time of consent. 2) Sex: Adults female subjects having dark spots/pigmentation caused by acne spots, sunspots age spots. 3) Females of childbearing potential should have a self-reported negative urine pregnancy test at the time of screening visit. 4) Subjects should not have used any cosmetic, nutraceutical or therapeutic products for skin pigmentation in last 6 months. 5) Subjects must be willing to stop using any cosmetics or any medical products for skin pigmentation for the duration of the study. 6) Subjects are not allowed to participate in any other study until this study is complete. 7) Subjects must be willing and able to follow the study directions and to return for all specified visits with the product. 8) Subjects must agree to record each use of the test products in the subject s diary card on daily basis. 9) Subjects must agree to record medication use during the study.
Exclusion criteria
Exclusion criteria: 1) Subjects who are on steroids for last six months. 2) Subjects who have used any cosmetic, nutraceutical or therapeutic products for skin last six months. 3) Subjects with other dermatologic diseases whose presence or treatments could interfere with the assessment of study. 4) Subjects that are pregnant and/or breastfeeding. 5) The subject has a known allergy or sensitivity to soaps, lotions, detergents, detanglers or fragrances. 6) Subjects if do not agree to limit sun exposure to affected areas such as face during prolonged sun exposure. 7) The subject has any other skin conditions i.e. cuts, scratches, active acne, ring worms, etc. which in the opinion of the Investigator, will interfere with the study results or will create undue risk for the subject. 8) The subject has any of the conditions or factors that the Investigator believes may affect the response of the skin or the interpretation of the test results. 9) The subject is currently taking or has taken any medication, which the Investigator believes may influence the interpretation of the data.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.To evaluate the effectiveness of the test product in terms of change in skin erythema and melanin from baseline before usage and after usage of the test product. 2.To evaluate the effectiveness of the test product in terms of change in in skin color parameters from baseline before usage and after usage of the test product. Timepoint: Day 01, Day 30 and Day 60 | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.To evaluate the effectiveness of test product in terms of reduction in dark spots from baseline before and after usage of the test product. 2.To evaluate the effectiveness of test product in terms of change in comedones from baseline before and after usage of the test product. 3.To evaluate the effectiveness of test product in terms of change in skin brightness from baseline before and after usage of the test product. 4.To evaluate the effectiveness of test product in terms of change in facial appearance from baseline and after usage of the test product. 5.To evaluate the effectiveness of the test product in terms of subjective product perception regarding the test product s effect on dark spots reduction, appearance, radiance, acne or skin breakouts, glowing skin tone, blemishes and dark skin patches reduction from baseline before usage and after usage of the test product Timepoint: Day 01, Day 30 and Day 60 | — |
Countries
India
Contacts
Public ContactDr Maheshvari Patel
NovoBliss Research Private Limited
Outcome results
None listed